| Identification | Back Directory | [Name]
ChartarlactaM A | [CAS]
1528745-88-1 | [Synonyms]
ChartarlactaM A
Spiro[2H-furo[2,3-e]isoindole-2,1'(2'H)-naphthalene]-6,8(3H,7H)-dione, 3',4',4'a,5',6',7',8',8'a-octahydro-4,6'-dihydroxy-2',5',5',8'a-tetramethyl-, (1'R,2'R,4'aS,6'R,8'aS)- | [Molecular Formula]
C23H29NO5 | [MDL Number]
MFCD32645076 | [MOL File]
1528745-88-1.mol | [Molecular Weight]
399.48 |
| Hazard Information | Back Directory | [Uses]
Chartarlactam A is a novel compound with anti-hyperlipidemic activity. Chartarlactam A exhibits inhibitory potential in HepG2 cells[1]. | [References]
[1] Chartarlactams A-P, phenylspirodrimanes from the sponge-associated fungus Stachybotrys chartarum with antihyperlipidemic activities |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|